FASTK

FASTK is a multifunctional signaling kinase and RNA-processing regulator that operates across mitochondrial, cytoplasmic, and nuclear compartments. Upon Fas receptor ligation, FASTK is dephosphorylated and activated, whereupon it phosphorylates the RNA-binding protein TIA-1 upstream of apoptotic DNA fragmentation (PMID:7544399). Under basal conditions FASTK localizes to the outer mitochondrial membrane, but upon stress it translocates to cytoplasmic stress granules to modulate translational silencing via TIA-1 interaction, and also resides in nuclear speckles where it promotes FGFR2 exon IIIb inclusion through a U-rich intronic element independently of TIA-1 (PMID:17592127). As the founding member of the FASTK family, it shares a RAP domain architecture that enables RNA binding and participates in post-transcriptional regulation of mitochondrial gene expression, with family members collectively governing non-canonical RNA junction processing, ribosome assembly, and mitochondrial translation (PMID:29036396, PMID:34748562).

1. 1995 High

   The identification of FASTK as a Fas-activated kinase that phosphorylates TIA-1 established the first direct biochemical link between Fas death-receptor signaling and a downstream kinase–substrate pair operating upstream of DNA fragmentation.

   Evidence In vitro kinase assays and immunoprecipitation in Fas-ligated Jurkat cells

   PMID:7544399

   Open questions at the time

   • The structural basis of FASTK kinase activity and its activation by dephosphorylation remains undefined
   • Whether TIA-1 phosphorylation is necessary and sufficient for downstream DNA fragmentation was not tested
   • The kinase(s) and phosphatase(s) that regulate FASTK phosphorylation status are unknown
2. 2007 High

   Demonstration that FASTK resides on the outer mitochondrial membrane yet dynamically relocates to stress granules and nuclear speckles revealed it as a tri-compartmental protein with separable functions in translational silencing (via TIA-1) and alternative splicing (TIA-1-independent promotion of FGFR2 exon IIIb inclusion).

   Evidence Two-hybrid screens, co-immunoprecipitation, siRNA knockdown, minigene splicing assays, and immunofluorescence in mammalian cells

   PMID:17592127

   Open questions at the time

   • The signals triggering FASTK redistribution among the three compartments are not characterized
   • The mechanism by which FASTK recognizes the IAS1 U-rich element to promote exon inclusion is unresolved
   • Whether the kinase activity of FASTK is required for its splicing or stress-granule functions was not determined
3. 2013 Medium

   Validation of FASTK as a direct miR-106a-5p target whose depletion suppresses proliferation and migration while promoting apoptosis in astrocytoma cells placed FASTK in a pro-survival, pro-proliferative role in a cancer context.

   Evidence Luciferase reporter assay for direct miRNA targeting, siRNA knockdown with proliferation, migration, and apoptosis assays in astrocytoma cells

   PMID:24013584

   Open questions at the time

   • The downstream effectors through which FASTK promotes proliferation and migration were not identified
   • Findings are from a single cancer cell type without in vivo validation
   • Whether the kinase activity or RNA-regulatory functions of FASTK mediate these phenotypes is unknown
4. 2017 Medium

   A systematic review consolidated evidence that the FASTK family shares a RAP domain enabling RNA binding and collectively governs mitochondrial mRNA processing, ribosome assembly, and translation, reframing FASTK as the founding member of a mitochondrial RNA-regulatory family.

   Evidence Review synthesizing biochemical, genetic, and cell-biology studies across FASTK family members

   PMID:29036396

   Open questions at the time

   • The specific mitochondrial RNA targets of FASTK itself (as opposed to its paralogs) were not delineated
   • No structural data for any FASTK-family RAP domain were available
   • Whether FASTK and its paralogs function redundantly or in a coordinated manner was not resolved
5. 2021 High

   CRISPR knockouts demonstrated that FASTK family members, especially FASTKD4 and FASTKD5, are required for non-canonical RNA junction processing of the mitochondrial transcriptome, with FASTKD5 loss causing severe translation and oxidative phosphorylation defects, providing direct genetic evidence for the family's essential role in mitochondrial gene expression.

   Evidence Single and combinatorial CRISPR/Cas9 knockouts in human cell lines with mitochondrial transcriptome sequencing, translation assays, and respiration measurements

   PMID:34748562

   Open questions at the time

   • The specific contribution of FASTK itself (versus FASTKD4/D5) to junction processing was not isolated
   • The mechanism by which individual family members recognize their target RNA junctions is unknown
   • In vivo physiological consequences of FASTK family loss in animal models have not been reported

• A key unresolved question is how the kinase activity, RNA-regulatory functions, and dynamic subcellular redistribution of FASTK are coordinated, and which specific mitochondrial RNA targets FASTK itself processes independently of its paralogs.
• No structural model of full-length FASTK or its RAP domain exists
• The relationship between FASTK kinase activity and its RNA-regulatory roles has never been tested
• Specific mitochondrial transcript targets of FASTK (not paralogs) remain to be defined by loss-of-function approaches